Survival and tumour control probability in tumours with heterogeneous oxygenation: A comparison between the linear-quadratic and the universal survival curve models for high doses

References

• Barendsen GW. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982;8:1981–97.
   PubMed Web of Science ®Google Scholar
• Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 2008;18:234–9.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick JP, Meyer JJ, Marks LB. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 2008;18:240–3.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick JP, Brenner DJ, Orton CG. Point/Counterpoint. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Med Phys 2009;36: 3381–4.
   PubMed Web of Science ®Google Scholar
• Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:847–52.
   PubMed Web of Science ®Google Scholar
• Hall EJ, Giaccia AJ. Radiobiology for the radiologist, 6th ed. Philadelphia: Lippincott/Williams & Wilkins; 2006.
   Google Scholar
• Wennberg BM, Baumann P, Gagliardi G, Nyman J, Drugge N, Hoyer M, et al. NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction. Acta Oncol 2011;50:518–27.
   PubMed Web of Science ®Google Scholar
• Wennberg B, Lax I. The impact of fractionation in SBRT: Analysis with the linear quadratic model and the universal survival curve model. Acta Oncol 2013;52:902–909.
   PubMed Web of Science ®Google Scholar
• Toma-Dasu I, Dasu A. Modelling tumour oxygenation, reoxygenation and implications on treatment outcome. Comput Math Methods Med 2013;2013:141087.
   PubMed Web of Science ®Google Scholar
• Daşu A, Toma-Daşu I, Karlsson M. Theoretical simulation of tumour oxygenation and results from acute and chronic hypoxia. Phys Med Biol 2003;48:2829–42.
   PubMed Web of Science ®Google Scholar
• Daşu A, Toma-Daşu I, Karlsson M. The effects of hypoxia on the theoretical modelling of tumour control probability. Acta Oncol 2005;44:563–71.
   PubMed Web of Science ®Google Scholar
• Toma-Daşu I, Daşu A, Brahme A. Dose prescription and optimisation based on tumour hypoxia. Acta Oncol 2009; 48:1181–92.
   PubMed Web of Science ®Google Scholar
• Alper T. Cellular radiobiology. Cambridge, UK: Cambridge University Press; 1979.
   Google Scholar
• Daşu A, Toma-Daşu I. Prostate alpha/beta revisited – an analysis of clinical results from 14 168 patients. Acta Oncol 2012;51:963–74.
   PubMed Web of Science ®Google Scholar
• Ljungkvist AS, Bussink J, Kaanders JH, Wiedenmann NE, Vlasman R, van der Kogel AJ. Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumour model. Rad Res 2006;165:326–36.
   PubMed Web of Science ®Google Scholar
• Ljungkvist AS, Bussink J, Kaanders JH, Rijken PF, Begg AC, Raleigh JA, et al. Hypoxic cell turnover in different solid tumor lines. Int J Rad Oncol Biol Phys 2005;62: 1157–68.
   PubMed Web of Science ®Google Scholar
• Lax I, Blomgren H, Näslund I, Svanström R. Stereotactic radiotherapy of malignancies in the abdomen. Acta Oncol 1994;33:677–83.
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Näslund I, Svanström R. Stereotactic high dose fraction radiation therapy of extracranial tumours using an accelerator. Acta Oncol 1995;34:861–70.
   PubMed Web of Science ®Google Scholar
• Høyer M, Muren LP. Stereotactic body radiation therapy – a discipline with Nordic origin and profile. Acta Oncol 2012;51:564–7.
   PubMed Web of Science ®Google Scholar
• Chang UK, Cho WI, Kim MS, Cho CK, Lee DH, Rhee CH. Local control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group. Acta Oncol 2012;51: 589–95.
   PubMed Web of Science ®Google Scholar
• Scorsetti M, Alongi F, Filippi AR, Pentimalli S, Navarria P, Clerici E, et al. Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: A retrospective analysis of 34 patients. Acta Oncol 2012;51:618–23.
   PubMed Web of Science ®Google Scholar
• Fowler J. Linear quadratics is alive and well: In regard to Park et al. (Int J Radiat Oncol Biol Phys 2008;70:847–52). Int J Radiat Oncol Biol Phys 2008;72:957–9.
   PubMed Web of Science ®Google Scholar
• McKenna F, Ahmad S. Toward a unified survival curve: In regard to Kavanagh and Newman (Int J Radiat Oncol Biol Phys 2008;71:958–9) and Park et al. (Int J Radiat Oncol Biol Phys 2008;70:847–52). Int J Radiat Oncol Biol Phys 2009;73:640.
   PubMedGoogle Scholar